Biopharmaceuticals Market Statistics with Top Factors which Boost the Industry around the Globe

Pharmaceutical companies have streamlined drug discovery and development through the adoption of biopharmaceuticals. Biopharmaceuticals and therapeutic proteins have immensely aided in target-based treatment for chronic diseases, especially cancer.

Biopharmaceuticals Market is expected to touch $526,008 million by 2025, increasing at a CAGR of 13.8% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

Biopharmaceuticals, also known as biologics, are drugs that are manufactured in living systems, such as microorganisms and animal cells. An array of different biopharmaceuticals is also produced using recombinant DNA technology. The biopharmaceuticals sector is the fastest-growing segment of the pharmaceutical industry.

The report provides an extensive competitive analysis and profiles of the key market players, such as Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer, Inc., and Sanofi. The other players in the value chain (not included in the report) include Bristol Myers Squibb Company, Bayer AG, and Shire plc.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/3971

The global biopharmaceuticals market is anticipated to grow considerably in the near future, owing to various factors, such as strategic collaborations among biopharmaceuticals companies, increase in obesity and sedentary lifestyle among the population, rise in an elderly population, and an upsurge in the prevalence of chronic diseases, such as cancer, globally. However, high costs associated with biopharmaceuticals drug development and a stringent regulatory scenario are key factors expected to impede the market growth. On the contrary, emerging markets, such as India and China, are anticipated to provide lucrative growth opportunities to the market players during the forecast period.

By type, the monoclonal antibody segment accounted for a nearly two-fifths share of the global biopharmaceuticals market in 2017. In terms of application, the oncology segment accounted for a one-third share in 2017 and is projected to exhibit a prominent growth rate, owing to a surge in cancer prevalence globally. By region, North America generated the highest revenue in the global biopharmaceuticals market in 2017.

Key Findings of the Biopharmaceuticals Market:
• The monoclonal antibody segment is anticipated to dominate the global biopharmaceuticals market from 2018 to 2025.
• The metabolic disease application is anticipated to grow with the highest CAGR throughout the forecast period.
• North America accounted for a share of more than two-fifths of the global biopharmaceuticals market in 2017.
• The Asia-Pacific region is anticipated to grow at the highest rate in the global biopharmaceuticals market during the forecast period, followed by LAMEA.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/3971

North America held the highest market share in 2017, owing to the high prevalence rate of cancer and other chronic diseases, the adoption of biologics, and an increase in awareness about biopharmaceuticals. The Asia-Pacific region is expected to grow at the highest CAGR of 17.2% during the forecast period, owing to rapid industrialization in the area, an increase in disposable income, and an upsurge in government initiatives to modernize the healthcare infrastructure.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.